Surgalign Holdings Inc
NASDAQ:SRGA
Intrinsic Value
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. [ Read More ]
The intrinsic value of one
SRGA
stock under the Base Case scenario is
6.857
USD.
Compared to the current market price of 0.011 USD,
Surgalign Holdings Inc
is
Undervalued by 100%.
Surgalign Holdings Inc's market capitalization is 101k USD.
SRGA stock price is 0.011 USD.
SRGA stock price (0.011 USD) is 100% less than its Intrinsic Value (6.857 USD).
SRGA. Open DCF Valuation
SRGA stock price (0.011 USD) is 100% less than its Relative Value (6.857 USD). Open Relative Valuation
SRGA.
SRGA's Revenue has been growing by 2% per year for the last 3 years.
SRGA's Revenue has dropped by 11% over the past 12 months.
SRGA's long-term liabilties (77m USD) exceed its long-term assets (68m USD).
SRGA's ROE (Return on Equity) has significantly decreased in the last 3 years from -48% to -377%, and is approaching profitability.
SRGA's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -36% to -130%, and is approaching profitability.
SRGA has negative Operating Income for the last twelve months.
SRGA has negative Net Income for the last twelve months.
SRGA's ROE (Return on Equity) for the past 12 months is negative and is equal to -377%.
SRGA's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -130%.
SRGA has negative Net Debt. This means that the company has more cash and short-term investments (22m USD) than debt (10m USD).
SRGA's short-term assets (53m USD) exceed its short-term liabilties (20m USD).
SRGA has positive Gross Profit for the last twelve months.
SRGA has negative Free Cash Flow for the last twelve months.
SRGA has negative three-year average ROE (Return on Equity): -478%. The company is not efficient at transforming stockholders' equity into net income.
SRGA has negative three-year average ROIC (Return on Invested Capital): -64%. The company is not efficient at using invested capital to generate operating income.
SRGA's D/E (Debt to Equity) is very low and is equal to -1.15.
SRGA's Altman Z-Score is very low and is equal to -14.68.
Fundamental Analysis
Surgalign Holdings Inc
Balance Sheet Decomposition
Surgalign Holdings Inc
| Current Assets | 53.4m |
| Cash & Short-Term Investments | 22.4m |
| Receivables | 15.4m |
| Other Current Assets | 15.6m |
| Non-Current Assets | 14.3m |
| PP&E | 3.6m |
| Other Non-Current Assets | 10.7m |
| Current Liabilities | 20m |
| Accounts Payable | 7.5m |
| Accrued Liabilities | 12.1m |
| Other Current Liabilities | 402k |
| Non-Current Liabilities | 56.7m |
| Long-Term Debt | 10.2m |
| Other Non-Current Liabilities | 46.4m |
Earnings Waterfall
Surgalign Holdings Inc
|
Revenue
|
78.1m
USD
|
|
Cost of Revenue
|
-41.4m
USD
|
|
Gross Profit
|
36.8m
USD
|
|
Operating Expenses
|
-105m
USD
|
|
Operating Income
|
-68.2m
USD
|
|
Other Expenses
|
17.7m
USD
|
|
Net Income
|
-50.5m
USD
|
Free Cash Flow Analysis
Surgalign Holdings Inc
What is Free Cash Flow?
SRGA Profitability Score
Profitability Due Diligence
Surgalign Holdings Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Surgalign Holdings Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
SRGA Solvency Score
Solvency Due Diligence
Surgalign Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Surgalign Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SRGA Price Targets Summary
Surgalign Holdings Inc
Ownership
SRGA Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
SRGA Price
Surgalign Holdings Inc
| Average Annual Return | -43.36% |
| Standard Deviation of Annual Returns | 19.77% |
| Max Drawdown | -100% |
| Market Capitalization | 101k USD |
| Shares Outstanding | 9 183 450 |
| Percentage of Shares Shorted | 0.74% |
Company Profile
Surgalign Holdings Inc
Country
Industry
Market Cap
Dividend Yield
Description
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
You don't have any saved screeners yet
